However, SOX2-positive tumors exhibited significantly faster metastasis after biochemical recurrence than SOX2-negative tumors, and SOX2-positive patients had higher prostate cancer-specific mortality and overall mortality rates.24 The gene discussed is SOX2; the disease is prostate cancer.